Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | Multi-Drug Resistance in Cancer

Multi-Drug Resistance in Cancer

Series: Methods in Molecular Biology, Vol. 596

Zhou, Jun (Ed.)

2010

A product of Humana Press
Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$119.00

(net) price for USA

ISBN 978-1-60761-416-6

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$159.00

(net) price for USA

ISBN 978-1-60761-415-9

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$159.00

(net) price for USA

ISBN 978-1-61779-664-7

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • Collects comprehensive reviews written by leading scientists in the field
  • Provides up-to-date techniques for detection and imaging of drug transporters
  • Offers strategies to evaluate the efficacy of resistance reversal agents

With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistically unrelated drugs, the efficacy of chemotherapeutic management of cancer often becomes severely limited. In Multi-Drug Resistance in Cancer, leading researchers in the field provide comprehensive and up-to-date reviews of multidrug resistance mechanisms, from over-expression of ATP-binding cassette drug transporters such as P-glycoprotein, multidrug resistance-associated proteins, and breast cancer resistance protein, to the drug ratio-dependent antagonism and the paradigm of cancer stem cells. The extensive volume also includes strategies to overcome multidrug resistance, from the development of compounds that inhibit drug transporter function to the modulation of transporter expression, as well as techniques for detection and imaging of drug transporters, methods for investigation of drug resistance in animal models, and strategies to evaluate the efficacy of resistance reversal agents. As a volume in the highly successful Methods in Molecular Biology™ series, this work provides the kind of detailed description and implementation advice that is crucial for getting optimal results.

Authoritative and cutting-edge, Multi-Drug Resistance in Cancer offers a state-of-art collection of reviews and methods for both basic and clinician investigators who are interested in the vital study of cancer multi-drug resistance mechanisms and reversal strategies.

Content Level » Research

Keywords » ATP-binding - Cancer stem cells - Chemotherapy - Drug transporter function - P-glycoproteins - Regulation - Resistance reversal agents - tissue

Related subjects » Cancer Research - Medical Microbiology - Oncology & Hematology

Table of contents 

1. Multidrug Resistance in Cancer Bruce C. Baguley 2. Multidrug Resistance in Oncology and Beyond: From Imaging of Drug Efflux Pumps to Cellular Drug Targets Wouter B. Nagengast, Thijs H. Oude Munnink, Eli C.F. Dijkers, Geke A.P. Hospers, Adrienne H. Brouwers, Carolien P. Schröder, Marjolijn Lub-de Hooge, and Elisabeth G.E. de Vries 3. Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer Sven Rottenberg, Marina Pajic, and Jos Jonkers 4. Mechanisms of Multidrug Resistance in Cancer Jean-Pierre Gillet and Michael M. Gottesman 5. Molecular Mechanisms of Drug Resistance in Single-Step and Multi-Step Drug-Selected Cancer Cells Anna Maria Calcagno and Suresh V. Ambudkar 6. Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications Ingolf Cascorbi and Sierk Haenisch 7. Flow Cytometric Evaluation of Multidrug Resistance Proteins Adorjan Aszalos and Barbara J. Taylor 8. Targeted Chemotherapy in Drug Resistant Tumors and Noninvasive Imaging of P-Glycoprotein-Mediated Functional Transport in Cancer Jothilingam Sivapackiam, Seth T. Gammon, Scott E. Harpstrite, and Vijay Sharma 9. Epigenetic Regulation of Multidrug Resistance 1 Gene Expression: Profiling CpG Methylation Status Using Bisulphite Sequencing Emma K. Baker and Assam El-Osta 10. Expression and Function of P-Glycoprotein in Normal Tissues: Effect on Pharmacokinetics Frantisek Staud, Martina Ceckova, Stanislav Micuda, and Petr Pavek 11. Molecular Mechanism of ATP-Dependent Solute Transport by Multidrug Resistance-Associated Protein 1 Xiu-bao Chang 12. Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes Douglas D. Ross and Takeo Nakanishi 13. Drug Ratio-Dependent Antagonism: A NewCategory of Multidrug Resistance and Strategies for Its Circumvention Troy O. Harasym, Barry D. Liboiron, and Lawrence D. Mayer 14. Reversing Agents for ATP-Binding Cassette Drug Transporters Chow H. Lee 15. Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors Helen M. Coley 16. Pharmacokinetic and Pharmacodynamic Implications of P-Glycoprotein Modulation Jeannie M. Padowski and Gary M. Pollack 17. Examination of CYP3A and P-Glycoprotein-Mediated Drug-Drug Interactions Using Animal Models Punit H. Marathe and A. David Rodrigues 18. Generating Inhibitors of P-Glycoprotein: Where to, Now? Emily Crowley, Christopher A. McDevitt, and Richard Callaghan 19. Immunosuppressors as Multidrug Resistance Reversal Agents Hamid Morjani and Claudie Madoulet 20. Overcoming Multidrug Resistance by RNA Interference Alexandra Stege, Andrea Krühn, and Hermann Lage 21. Circumventing Tumor Resistance to Chemotherapy by Nanotechnology Xing-Jie Liang, Chunying Chen, Yuliang Zhao, and Paul C. Wang

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Oncology.